Diseases

T433X5S

Adverse effect of phenothiazine antipsychotics and neuroleptics, sequela

T433X5D

Adverse effect of phenothiazine antipsychotics and neuroleptics, subsequent encounter

T444X5A

Adverse effect of predominantly alpha-adrenoreceptor agonists, initial encounter

T444X5S

Adverse effect of predominantly alpha-adrenoreceptor agonists, sequela

T444X5D

Adverse effect of predominantly alpha-adrenoreceptor agonists, subsequent encounter

T445X5A

Adverse effect of predominantly beta-adrenoreceptor agonists, initial encounter

T445X5S

Adverse effect of predominantly beta-adrenoreceptor agonists, sequela

T445X5D

Adverse effect of predominantly beta-adrenoreceptor agonists, subsequent encounter

T39315A

Adverse effect of propionic acid derivatives, initial encounter

T39315S

Adverse effect of propionic acid derivatives, sequela

T39315D

Adverse effect of propionic acid derivatives, subsequent encounter

T392X5A

Adverse effect of pyrazolone derivatives, initial encounter

T392X5S

Adverse effect of pyrazolone derivatives, sequela

T392X5D

Adverse effect of pyrazolone derivatives, subsequent encounter

T366X5A

Adverse effect of rifampicins, initial encounter

T366X5S

Adverse effect of rifampicins, sequela

T366X5D

Adverse effect of rifampicins, subsequent encounter

T39095A

Adverse effect of salicylates, initial encounter

T39095S

Adverse effect of salicylates, sequela

T39095D

Adverse effect of salicylates, subsequent encounter

T473X5A

Adverse effect of saline and osmotic laxatives, initial encounter

T473X5S

Adverse effect of saline and osmotic laxatives, sequela

T473X5D

Adverse effect of saline and osmotic laxatives, subsequent encounter

T43215A

Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter

T43215S

Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, sequela

T43215D

Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, subsequent encounter

T43225A

Adverse effect of selective serotonin reuptake inhibitors, initial encounter

T43225S

Adverse effect of selective serotonin reuptake inhibitors, sequela

T43225D

Adverse effect of selective serotonin reuptake inhibitors, subsequent encounter

T481X5A

Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter

T481X5S

Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], sequela

T481X5D

Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], subsequent encounter

T50B15A

Adverse effect of smallpox vaccines, initial encounter

T50B15S

Adverse effect of smallpox vaccines, sequela

T50B15D

Adverse effect of smallpox vaccines, subsequent encounter

T472X5A

Adverse effect of stimulant laxatives, initial encounter

T472X5S

Adverse effect of stimulant laxatives, sequela

T472X5D

Adverse effect of stimulant laxatives, subsequent encounter

T422X5A

Adverse effect of succinimides and oxazolidinediones, initial encounter

T422X5S

Adverse effect of succinimides and oxazolidinediones, sequela

T422X5D

Adverse effect of succinimides and oxazolidinediones, subsequent encounter

T370X5A

Adverse effect of sulfonamides, initial encounter

T370X5S

Adverse effect of sulfonamides, sequela

T370X5D

Adverse effect of sulfonamides, subsequent encounter

T40725A

Adverse effect of synthetic cannabinoids, initial encounter

T40725S

Adverse effect of synthetic cannabinoids, sequela

T40725D

Adverse effect of synthetic cannabinoids, subsequent encounter

T43025A

Adverse effect of tetracyclic antidepressants, initial encounter

T43025S

Adverse effect of tetracyclic antidepressants, sequela

T43025D

Adverse effect of tetracyclic antidepressants, subsequent encounter

T364X5A

Adverse effect of tetracyclines, initial encounter

T364X5S

Adverse effect of tetracyclines, sequela

T364X5D

Adverse effect of tetracyclines, subsequent encounter

T415X5A

Adverse effect of therapeutic gases, initial encounter

T415X5S

Adverse effect of therapeutic gases, sequela

T415X5D

Adverse effect of therapeutic gases, subsequent encounter

T45615A

Adverse effect of thrombolytic drugs, initial encounter

T45615S

Adverse effect of thrombolytic drugs, sequela

T45615D

Adverse effect of thrombolytic drugs, subsequent encounter

T381X5A

Adverse effect of thyroid hormones and substitutes, initial encounter

T381X5S

Adverse effect of thyroid hormones and substitutes, sequela

T381X5D

Adverse effect of thyroid hormones and substitutes, subsequent encounter

T40425A

Adverse effect of tramadol, initial encounter

T40425S

Adverse effect of tramadol, sequela

T40425D

Adverse effect of tramadol, subsequent encounter

T43015A

Adverse effect of tricyclic antidepressants, initial encounter

T43015S

Adverse effect of tricyclic antidepressants, sequela

T43015D

Adverse effect of tricyclic antidepressants, subsequent encounter

T48905A

Adverse effect of unspecified agents primarily acting on the respiratory system, initial encounter

T48905S

Adverse effect of unspecified agents primarily acting on the respiratory system, sequela

T48905D

Adverse effect of unspecified agents primarily acting on the respiratory system, subsequent encounter

T46905A

Adverse effect of unspecified agents primarily affecting the cardiovascular system, initial encounter

T46905S

Adverse effect of unspecified agents primarily affecting the cardiovascular system, sequela

T46905D

Adverse effect of unspecified agents primarily affecting the cardiovascular system, subsequent encounter

T4795XA

Adverse effect of unspecified agents primarily affecting the gastrointestinal system, initial encounter

T4795XS

Adverse effect of unspecified agents primarily affecting the gastrointestinal system, sequela

T4795XD

Adverse effect of unspecified agents primarily affecting the gastrointestinal system, subsequent encounter

T4145XA

Adverse effect of unspecified anesthetic, initial encounter

T4145XS

Adverse effect of unspecified anesthetic, sequela

T4145XD

Adverse effect of unspecified anesthetic, subsequent encounter

T43205A

Adverse effect of unspecified antidepressants, initial encounter

T43205S

Adverse effect of unspecified antidepressants, sequela

T43205D

Adverse effect of unspecified antidepressants, subsequent encounter

T4275XA

Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter

T4275XS

Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, sequela

T4275XD

Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, subsequent encounter

T43505A

Adverse effect of unspecified antipsychotics and neuroleptics, initial encounter

T43505S

Adverse effect of unspecified antipsychotics and neuroleptics, sequela

T43505D

Adverse effect of unspecified antipsychotics and neuroleptics, subsequent encounter

T48205A

Adverse effect of unspecified drugs acting on muscles, initial encounter

T48205S

Adverse effect of unspecified drugs acting on muscles, sequela

T48205D

Adverse effect of unspecified drugs acting on muscles, subsequent encounter

T44905A

Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, initial encounter

T44905S

Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, sequela

T44905D

Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, subsequent encounter

T50905A

Adverse effect of unspecified drugs, medicaments and biological substances, initial encounter

T50905S

Adverse effect of unspecified drugs, medicaments and biological substances, sequela

T50905D

Adverse effect of unspecified drugs, medicaments and biological substances, subsequent encounter

T45605A

Adverse effect of unspecified fibrinolysis-affecting drugs, initial encounter

T45605S

Adverse effect of unspecified fibrinolysis-affecting drugs, sequela